New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
08:04 EDTNUVANuVasive sees Q4 revenue $189M, consensus $176.43M
CEO Alex Lukianov said, "I am exceptionally pleased to report fantastic revenue results in conjunction with strong profit translation for the full year 2013. Revenue growth was roughly ten percent, outperforming our expectations and well ahead of spine market growth overall."
News For NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 1, 2015
15:39 EDTNUVANuVasive CEO departure increases likelihood of acquisition, says Brean Capital
Subscribe for More Information
12:49 EDTNUVANuVasive culture change a positive, says Wells Fargo
Wells Fargo expects a change to NuVasive's culture with the resignation of CEO Alex Lukianov resignation and COO Keith Valentine's recent departure. Wells says that while some near-term disruption is possible, it views the change as positive since the company is transitioning from a small spine player to the number three spine company in the world. The firm keeps an Outperform rating on the name.
10:16 EDTNUVANuVasive news should not hurt ability to hit guidance, says Piper Jaffray
Subscribe for More Information
08:37 EDTNUVANuVasive sees Q1 revenue exceeding $190M, consensus $189.32M
NuVasive announced that it anticipates Q1 revenue will be in excess of $190M, including more than $2M of currency headwinds, and remains on track for 2015 profitability goals. The company will announce complete financial and operating results on Q1 performance and review its guidance for FY15 when it reports Q1 results.
08:34 EDTNUVANuVasive CEO steps down, Gregory Lucier appointed chairman, interim CEO
Subscribe for More Information
March 24, 2015
07:34 EDTNUVACanaccord to hold a conference
Musculoskeletal Conference is being held in Las Vegas on March 24.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use